- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1327EUR$1,500USD£1,148GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1770EUR$2,000USD£1,530GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1106EUR$1,250USD£956GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1106EUR$1,250USD£956GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1770EUR$2,000USD£1,530GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1327EUR$1,500USD£1,148GBP
- Report
- September 2025
- 371 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 280 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 379 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- April 2025
- 182 Pages
Global
From €3982EUR$4,500USD£3,443GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1106EUR$1,250USD£956GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1327EUR$1,500USD£1,148GBP
- Report
- February 2025
- 185 Pages
Global
From €3982EUR$4,500USD£3,443GBP
- Report
- August 2025
- 150 Pages
Global
From €2971EUR$3,358USD£2,569GBP
€3495EUR$3,950USD£3,022GBP
- Report
- July 2025
- 350 Pages
Global
From €4379EUR$4,949USD£3,787GBP
- Report
- June 2025
- 150 Pages
Global
From €2388EUR$2,699USD£2,065GBP
- Report
- June 2025
- 200 Pages
Global
From €2468EUR$2,789USD£2,134GBP
- Report
- May 2025
- 134 Pages
Global
From €13268EUR$14,995USD£11,473GBP
- Report
- December 2024
- 59 Pages
Global
From €3535EUR$3,995USD£3,057GBP
- Report
- January 2025
- 95 Pages
Global
From €3500EUR$4,237USD£3,132GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more